A research group from Nagoya University in Japan has developed an artificial intelligence for analyzing cell images that uses machine learning to predict the therapeutic effect of drugs. Called in silico FOCUS, this new technology may aid in the discovery of therapeutic agents for neurodegenerative disorders such as Kennedy disease.

A recent study demonstrates that machine learning methods could determine the risk of a viral jump or “spillover” from animals to humans using viral genomes. The research models predicted that genetically similar nonhuman primate viruses had an increased risk of human transmission, which was not the case with other animal groups.

Source: AI can help humans inspect chest X-rays for COVID-19, but the technology is unfit to serve as a standalone diagnostic tool for that purpose, according to a prospective observational study conducted at the University of Minnesota and published online June 1 in Radiology: Artificial Intelligence.

Source: St Vincent’s Hospital Sydney has entered into a multi-year collaboration with imaging solutions developer Sydney Neuroimaging Analysis Centre to co-develop and deploy novel AI diagnostics solutions. According to a media release, the partnership will bring together AI engineers, radiologists, imaging analysts, expert clinicians and data, utilising SNAC’s technology platform to drive large-scale deployment of...

Source: A robotic AI system has been developed by scientists that is capable of improving stem cell procedures that are utilized in regenerative medicine.  The development of the robotic AI system was carried out by a joint research group led by Genki Kanda at the RIKEN Center for Biosystems Dynamics Research (BDR). The peer-reviewed research was published...

Source: University of Helsinki Introducing the ‘motor assessment of infants jumpsuit’ (MAIJU), it looks exactly like typical baby clothing, but there is a crucial difference – it is full of sensors which assess child development. It’s a romper suit being piloted in Helsinki, Copenhagen and Pisa. “MAIJU offers the first of its kind quantitative assessment of...

Doctor’s have been able to monitor a patient’s healthcare progress through electronic health records. Now, a new technology program called “Physician Insights” uses artificial intelligence to track a patient’s health outside of their exam room. The Insights tool, created by “agilon health,” measures how often PCPs are doing wellness visits, how often they check in...

Source: The fourth annual Women in Medicine conference was held on Friday, April 22. It was held in-person for the first time in three years. The theme of this year’s all-day conference, which was also live-streamed, was “Celebrating Our Voices,” and featured presentations and discussion panels that shed light on the gender disparities that exist...

Source: A new program aimed at the increasing number of Aboriginal and Torres Strait Islander doctors interested in undertaking non-GP specialist medical training, has secured funding in a first for the Australian medical workforce. This will see Indigenous non-GP medical specialists in Australia supported through a unique specialist trainee network, as well as a range...

Source: A new observational study has found an association between the consumption of artificial sweeteners, such as aspartame and acesulfame-K, to cancer. The worldwide artificial sweetener market is estimated at $22.2 billion and rising, a nearly three-billion-dollar increase in the last 2 years alone.